Thursday, May 22, 2008

Director's Comments: Research Rigor

Listen to the NLM Director's Comments on Research Rigor. The transcript is also available.

Two recent studies and a commentary in the Journal of the American Medical Association candidly reveal that some refereed clinical research sponsored by for-profit companies needs more rigor, reconsideration, and reform. Two JAMA studies suggest a pharmaceutical company apparently misrepresented research data, plus allegedly manipulated clinical research articles and reviews that were published widely in internationally respected, refereed, medical journals (including JAMA)...


[Source: What's New on MedlinePlus]

No comments: